Background
Despite the efficacy of antiretroviral therapy (ART), many people living with HIV-1 (PLWH) show persistent immune activation and harbour latent reservoirs that hinder long-term disease management. The gut-associated lymphoid tissue (GALT), established early as the main HIV reservoir, is marked by massive CD4+ T-cell loss and high viral replication. Human endogenous retroviruses (HERVs), remnants of ancient retroviral infections that account for 8% of the human genome, have been linked to chronic inflammation and HIV-1 infection. We have previously shown their association with persistent immune activation in virologically suppressed PLWH. Here, we evaluated HERV transcriptional activity, immune activation, and HIV reservoirs in blood and GALT from virologically suppressed PLWH, aiming to identify novel markers for clinical monitoring.
Methods
31 HIV-1+ viral suppressed patients, and 10 Healthy Donors (HD) were enrolled. Blood and GALT HIV-DNA levels and residual plasma viremia were quantified by droplet digital-PCR system. The expression of the env gene of HERV-K113 and HERV-K111, of pHERV-W, Syncitin-1 (SYN-1) and HERV-H have been analysed from blood samples by RT-Real time PCR. The immunophenotyping have been evaluated by flow cytometry. The non-parametric Mann-Whitney test and the Spearman Correlation were used for statistical analysis
Results
In virologically suppressed PLWH, HERV-K113, HERV-K111 and pHERV-W were significantly high expressed compared to HD. HERV-K113 and HERV-K111 levels correlated positively with blood HIV-DNA and CD8+ T-cell and CD19+ B-cell activation markers in the peripheral blood district, whereas they correlated inversely with CD4 count and nadir. Furthermore, the activation of HERVs and immune system observed in the peripheral blood was found to correlate directly and significantly with the immune activation measured in GALT. Notably, HERV-K113, HERV-K111 and pHERV-W expression positively correlated with CD38 and HLADR activation markers in CD4 and CD8 lymphocytes in GALT.
Conclusions
The analysis suggests that HERV expression may play a role in immune dysregulation and viral persistence in people living with HIV. Immune activation in both blood and GALT highlights a systemic connection between peripheral and mucosal immunity. Monitoring HERV expression could offer valuable insights into chronic inflammation and HIV latency, potentially driving the development of targeted therapies.